IBDEI09S ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4157,1,3,0)
 ;;=3^SCRN MAL NEOP MAMMO
 ;;^UTILITY(U,$J,358.3,4157,1,4,0)
 ;;=4^V76.12
 ;;^UTILITY(U,$J,358.3,4157,2)
 ;;=^317970
 ;;^UTILITY(U,$J,358.3,4158,0)
 ;;=V76.2^^17^196^67
 ;;^UTILITY(U,$J,358.3,4158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4158,1,3,0)
 ;;=3^SCRN MAL NEOP CERVIX
 ;;^UTILITY(U,$J,358.3,4158,1,4,0)
 ;;=4^V76.2
 ;;^UTILITY(U,$J,358.3,4158,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,4159,0)
 ;;=V76.3^^17^196^65
 ;;^UTILITY(U,$J,358.3,4159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4159,1,3,0)
 ;;=3^SCRN MAL NEOP BLADDER
 ;;^UTILITY(U,$J,358.3,4159,1,4,0)
 ;;=4^V76.3
 ;;^UTILITY(U,$J,358.3,4159,2)
 ;;=^295654
 ;;^UTILITY(U,$J,358.3,4160,0)
 ;;=V76.41^^17^196^76
 ;;^UTILITY(U,$J,358.3,4160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4160,1,3,0)
 ;;=3^SCRN MAL NEOP RECTUM
 ;;^UTILITY(U,$J,358.3,4160,1,4,0)
 ;;=4^V76.41
 ;;^UTILITY(U,$J,358.3,4160,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,4161,0)
 ;;=V76.42^^17^196^73
 ;;^UTILITY(U,$J,358.3,4161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4161,1,3,0)
 ;;=3^SCRN MAL NEOP ORAL CAV
 ;;^UTILITY(U,$J,358.3,4161,1,4,0)
 ;;=4^V76.42
 ;;^UTILITY(U,$J,358.3,4161,2)
 ;;=^295656
 ;;^UTILITY(U,$J,358.3,4162,0)
 ;;=V76.43^^17^196^78
 ;;^UTILITY(U,$J,358.3,4162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4162,1,3,0)
 ;;=3^SCRN MAL NEOP SKIN
 ;;^UTILITY(U,$J,358.3,4162,1,4,0)
 ;;=4^V76.43
 ;;^UTILITY(U,$J,358.3,4162,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,4163,0)
 ;;=V76.44^^17^196^75
 ;;^UTILITY(U,$J,358.3,4163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4163,1,3,0)
 ;;=3^SCRN MAL NEOP PROSTATE
 ;;^UTILITY(U,$J,358.3,4163,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,4163,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,4164,0)
 ;;=V76.45^^17^196^79
 ;;^UTILITY(U,$J,358.3,4164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4164,1,3,0)
 ;;=3^SCRN MAL NEOP TESTIS
 ;;^UTILITY(U,$J,358.3,4164,1,4,0)
 ;;=4^V76.45
 ;;^UTILITY(U,$J,358.3,4164,2)
 ;;=^321549
 ;;^UTILITY(U,$J,358.3,4165,0)
 ;;=V76.46^^17^196^74
 ;;^UTILITY(U,$J,358.3,4165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4165,1,3,0)
 ;;=3^SCRN MAL NEOP OVARY
 ;;^UTILITY(U,$J,358.3,4165,1,4,0)
 ;;=4^V76.46
 ;;^UTILITY(U,$J,358.3,4165,2)
 ;;=^322084
 ;;^UTILITY(U,$J,358.3,4166,0)
 ;;=V76.47^^17^196^80
 ;;^UTILITY(U,$J,358.3,4166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4166,1,3,0)
 ;;=3^SCRN MAL NEOP VAGINA
 ;;^UTILITY(U,$J,358.3,4166,1,4,0)
 ;;=4^V76.47
 ;;^UTILITY(U,$J,358.3,4166,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,4167,0)
 ;;=V76.51^^17^196^69
 ;;^UTILITY(U,$J,358.3,4167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4167,1,3,0)
 ;;=3^SCRN MAL NEOP INTESTINE
 ;;^UTILITY(U,$J,358.3,4167,1,4,0)
 ;;=4^V76.51
 ;;^UTILITY(U,$J,358.3,4167,2)
 ;;=^322089
 ;;^UTILITY(U,$J,358.3,4168,0)
 ;;=V76.81^^17^196^72
 ;;^UTILITY(U,$J,358.3,4168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4168,1,3,0)
 ;;=3^SCRN MAL NEOP NERVOUS SYSTEM
 ;;^UTILITY(U,$J,358.3,4168,1,4,0)
 ;;=4^V76.81
 ;;^UTILITY(U,$J,358.3,4168,2)
 ;;=^322091
 ;;^UTILITY(U,$J,358.3,4169,0)
 ;;=V77.0^^17^196^59
 ;;^UTILITY(U,$J,358.3,4169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4169,1,3,0)
 ;;=3^SCREEN-THYROID DISORDER
 ;;^UTILITY(U,$J,358.3,4169,1,4,0)
 ;;=4^V77.0
 ;;^UTILITY(U,$J,358.3,4169,2)
 ;;=^295661
 ;;^UTILITY(U,$J,358.3,4170,0)
 ;;=V77.1^^17^196^18
 ;;^UTILITY(U,$J,358.3,4170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4170,1,3,0)
 ;;=3^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,4170,1,4,0)
 ;;=4^V77.1
 ;;^UTILITY(U,$J,358.3,4170,2)
 ;;=^295662
 ;;^UTILITY(U,$J,358.3,4171,0)
 ;;=V77.2^^17^196^40
 ;;^UTILITY(U,$J,358.3,4171,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI09S
